ABOUT US

InnoCan is a speciality pharmaceutical company, improving quality of life, by developing outstanding products that harness the unique healing properties of Cannabinoids combined with smart delivery systems.

a highly experienced management team 

with a proven track record
in the pharmaceutical industry.

INNOCAN HARNESSES THE WIDE THERAPEUTIC POTENTIAL OF CANNABINOIDS

Cannabinoids interact with the endocannabinoid receptor system, which is located throughout the body and plays an important role in many processes. InnoCan aims to harness the power of cannabinoids to target a wide variety of health problems. InnoCan plans to initially innovate new dermatology treatments, where research shows topical cannabinoid-combined treatments are highly effective.
Endocannabinoid receptor system
Located throughout the body

Proven topical effect

INNOCAN HARNESSES THE WIDE THERAPEUTIC POTENTIAL OF CANNABINOIDS

TECHnology

Patent-pending formula & smart delivery system: “Release on demand”

Quality of life

Improved efficacy, administration and compliance

Clinically-proven

All out products are to be clinically proven with a Post Marketing Surveillance study.

OUR FIRST-LINE PRODUCTS

A new hope in PSORIASIS treatment

Psoriasis is a terrible auto-immune chronic skin disorder, affecting more than 7.5 million Americans –over 60% of psoriasis patients suffer from clinical depression! We at InnoCan want to change this.

Innovative Formula: Psoriasis Cream with Hemp Oil & Smart Delivery System:
Powerful synergistic effect of Salicylic Acid and Hemp Oil (Cannabinoid complex)
Release on demand for an “On-the-go” solution
Relief from Psoriasis: Itching, Irritation, Redness, Scaling, Inflammation

Safe, effective and easy to use

Free from coal tar and steroids

Non-drying and non-irritating

Relief from minor arthritis pain, backaches or muscle and joint pain

Cannabinoid absorbs quickly on the skin

Safe & easy-to-use

INNOVATIVE, FAST-ACTING PAIN RELIEF

1.5 billion people worldwide are affected by pain, with 50% of doctors’ visits pain related!

We at InnoCan want to help the millions of patients seeking better topicaltreatment options for a better quality of life.

Patent-pending, enhanced formula with smart delivery system

Powerful synergistic effect of Menthol & Methyl salicylate with Hemp oil (Cannabinoid complex)

Release on demand for an “On-the-go” solution

MULTI DISCIPLINARY MANAGEMENT TEAM WITH

Management Team

Ron Mayron

 Chairman

Extensive experience in the pharmaceutical & medical equipment arena. Significant senior management positions, both local and global, within Teva Pharmaceutical Industries Ltd. (incl. CEO Israel & VPIsrael and Africa). Oversaw Teva Medical (medical equipment), SLE (SCM solutions) and Abic Pharma (Marketing & Sales); annual sales turnover > $650 million & responsible for 730 employees. Ron serves as Director & Chairman of a variety of public and private companies.

Yoram Drucker

Founder

Successful Israeli entrepreneur and expert in the establishment and management of start-ups; overseeing operations, business development and product development. Co-founded three stem-cell technology companies: Pluristem (NASDAQ:PSTI), Brainstorm (NASDAQ:BCLI) and Cell Source Ltd (CLCS.OB).

Iris Bincovich

CEO

Vast experience and proven track record in developing global business strategies to open and penetrate new markets. Managed hundreds of successful international transactions from senior management positions (Kamedis, Efal). Accompanied startups from early stage to commercialization (Tagra). Established the infrastructure for a Global E-commerce site.

Moshe Haukalio

CFO

Vast CFO experience for public and private companies. Served as the CFO of Pfizer Israel, Merck-Serono and InterPharm. Extensive experience in Biotech.
Expert in business strategy, process improvement, and supply chain management. Accompanied fast-growing companies from early stage to the highly regulated arena of public companies

Nir Avram

CTO

Senior pharmaceutics and cosmetics consultant to start-ups and established companies, with more than 30 years of experience. Consults on a wide range of issues including pharmaceutical and cosmetic innovation, generic formulations, and the synthesis of new materials. Serves as VP R&D at Emilia Cosmetics Israel and Emilia Resources in the US. Previously VP R&D at Careline, a member of the pharmaceutical innovation team at Perrigo. He holds several patents.

Advisory Board

Zacki Turkeltaub

BD Consultant

Served as CEO, President, Chairman of the Board, Executive & non-Executive Board Director at public and private corporations, mainly in the USA. He has been involved with and led M&A transactions worth billions of dollars.

Dr. Stephen Cherkez

IP Strategy

Served as head of Teva’s Chemical Research Division; founder of Chem-Agis and President of its chemistry division; and VP BD at Agis. Since 2003, he has held a double position at Perrigo as VP Intellectual Property and VP Product Development. He has filed and participated in the writing of 33 patent families.

News

InnoCan Featured on the Financial News Channel, Bizportal

Read More

InnoCan TV Interview on Arutz Sheva

Read More >

InnoCan Featured in the Globes (English)

Read More >

Reshet.tv Talks About InnoCan

Read More >

InnoCan Published in the Globes (Hebrew)

Read More >

InnoCan Launches Equity Fundraising Campaign with PipelBiz

Read More >

CONTACT US

Yoram Drucker
YoramD@InnocanPharma.com
+972.54.471.1171

Iris Bincovich
IrisB@InnocanPharma.com
+972.54.301.2842